Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 5, 1999, Pages 651-659

  Dobsak, Petr ^a,b,c   Courderot Masuyer, Carol ^a   Zeller, Marianne ^a   Vergely, Catherine ^a   Laubriet, Aline ^a   Assem, Mahfoud ^a   Eicher, Jean Christophe ^b   Teyssier, Jean Raymond ^a   Wolf, Jean Eric ^b   Rochette, Luc ^a  

^a Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Experimentales   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Allophycocyanin; Apoptosis; Cardioplegia; Electron paramagnetic resonance; Heart transplantation; Isolated working rat heart; Pyruvate

Indexed keywords

PYRUVIC ACID;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON SPIN RESONANCE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOPLEGIC SOLUTIONS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; HEART ARREST, INDUCED; HYDROXYL RADICAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PYRUVIC ACID; RATS; RATS, WISTAR;

EID: 0032738998     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199911000-00005     Document Type: Article

References (36)

1. Chiu R. Cardioplegia. From the bedside to the laboratory and back again. Ann Thorac Surg 1991;52:1209-10.
2. Stringham J, Southard J, Hegge J, Triemstra L, Fields B, Belzer F. Limitations of heart preservation by cold storage. Transplantation 1992;53:287-94.
3. Hearse D, Bolli R. Reperfusion induced injury: manifestations, mechanisms and clinical relevance. Cardiovasc Res 1992;26: 101-8.
4. Hearse D, Braimbridge M, Jynge P. Principles of formulation and administration: protection of the ischemic myocardium: cardioplegia. New York: Raven Press, 1981:302-4.
5. Ledingham S, Braimbridge M, Hearse D. The St. Thomas hospital cardioplegia solution: a comparison of the efficacy of two formulations. J Thorac Cardiovasc Surg 1987;93:240-6.
6. Eicher JC, Gabrielle F, Abadie C, et al. Experimental preservation of the heart transplant: effects of deferoxamine on functional recovery and lipid peroxidation of the isolated-perfused rat heart subjected to ischemia and reperfusion. Transplant Proc 1995;27: 1654.
7. Abadie C, Ben Baouali A, Maupoil V, Rochelte L. An alpha-tocopherol analogue with antioxidant activity improves myocardial function during ischemia-reperfusion in isolated working rat hearts. Free Radic Biol Med 1993;15:209-15.
8. DeBoer L, Bekx P, Han L, Steinke L. Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation. Am J Physiol 1993;34:1571-6.
9. Kerr PM, Suleiman MS, Halestrap AP. Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate. Am J Physiol 1999;276:496-2.
10. Gottlied RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-8.
11. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 1996;93:11848-52.
12. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
13. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996;79:949-56.
14. Blasig IE, Shuter S, Garlick P, Slater T. Relative time-profiles for free radical trapping, coronary flow, enzyme leakage, arrhythmias, and function during myocardial reperfusion. Free Radic Biol Med 1994;16:35-41.
15. Maupoil V, Rochette L. Evaluation of free radical and lipid peroxide formation during global ischemia and reperfusion in isolated perfused rat heart. Cardiovasc Drugs Ther 1988;2:615-21.
16. Maupoil V, Rochette L, Tabard A, Clauser P, Harpey C. Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart. Cardiovasc Drugs Ther 1990;4:791-5.
17. Zweier JL, Kuppusamy P, Williams R, et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 1989;264:18890-5.
18. Vergely C, Maupoil V, Benderitter M, Rochette L. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic Biol Med 1998;3:470-9.
19. Yagi KA. A simple assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
20. Burton GW, Webb A, Inglod KU. A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 1985;20:29-39.
21. Chen C, Ma L, Linfert DR, et al. Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol 1997;30: 1407-12.
22. Cao G, Alessio H, Cutler R. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993;14:303-11.
23. +-ATPase by a free radical generating system containing t-butylhydroperoxide. Life Sci 1995;57:931-43.
24. Chen C, Ma L, Linfert DR, et al. Antioxidant effects of pyruvate in isolated rat hearts. J Mol Cell Cardiol 1995;27:2059-67.
25. Zweier J, Kuppusamy P, Lutty G. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A 1988;85:4046-50.
26. Crestanello J, Kamelgard J, Whitman G. The cumulative nature of pyruvate's dual mechanism for myocardial protection. J Surg Res 1995;59:198-204.
27. Bünger R, Mallet R, Hartman D. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart: near-complete prevention of reperfusion contractile failure. Eur J Biochem 1989;180:221-33.
28. Park JW, Chun YS, Kim MS, Park YC, Kwak SJ, Park SC. Metabolic modulation of cellular redox potential can improve cardiac recovery from ischemia-reperfusion injury. Int J Cardiol 1998;65: 139-17.
29. Scragg R, Jackon R, Holdaway I, Woolard G, Woolard D. Changes in plasma vitamin levels in the first 48 hours after onset of acute myocardial infarction. Am J Cardiol 1989;64:971-4.
30. Singal PK, Kirshenbaum LA. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 1990;6: 47-9.
31. Hill MF, Sinai PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-20.
32. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998;82:166-74.
33. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
34. Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilatator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992;263:92-5.
35. Kramer JH, Weglicki WB. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts. Free Radic Biol Med 1996;21:813-25.
36. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996;21:83-6.